CLINICAL_TRIALS trial_result · 2012-03-06

Clinical Trial Update: Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema [Phase 2]

Phase 2 trial evaluating aliskiren for diabetic macular edema was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 2 | Status: TERMINATED | Results posted: 2012-03-06